Inhibition of rat platelet aggregation by Urtica dioica leaves extracts. 2006

Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
Laboratoire de Physiologie et Ethnopharmacologie, UFR 'Physiologie et Pharmacologie', Département de biologie, Faculté des sciences, Université Mohamed Premier, BP 717, 60000 Oujda, Morocco.

Platelet hyperactivity plays an important role in arterial thrombosis and atherosclerosis. The present study was undertaken to investigate the effects of different extracts of Urtica dioica leaves on platelet aggregation. Rat platelets were prepared and incubated in vitro with different concentrations of the tested extracts and aggregation was induced by different agonists including thrombin (0.5 U/mL), ADP (10 microm), epinephrine (100 microm) and collagen (5 mg/mL). The crude aqueous extract inhibited thrombin-induced platelet aggregation in a dose-dependent manner. At 1 mg/mL, the percent inhibition was 17.1 +/- 4.2%. Soxhlet extraction of the plant leaves with different successive solvents showed that the ethyl acetate extract exhibited the most antiaggregant effect with an inhibition of 76.8 +/- 6.1% at 1 mg/mL. Flavonoids isolated from the plant leaves, produced a strong inhibitory effect on thrombin-induced platelet aggregation with an IC(50) of 0.25 +/- 0.05 and 0.40 +/- 0.04 mg/mL for genins and heterosidic flavonoids, respectively. Flavonoids also markedly inhibited platelet aggregation induced by ADP, collagen and epinephrine. It is concluded that Urtica dioica has an antiplatelet action in which flavonoids are mainly implicated. These results support the traditional use of Urtica dioica in the treatment and/or prevention of cardiovascular disease.

UI MeSH Term Description Entries
D008297 Male Males
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil

Related Publications

Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
June 2014, Iranian journal of basic medical sciences,
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
June 2010, Phytotherapy research : PTR,
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
September 2022, Molecules (Basel, Switzerland),
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
November 2007, Journal of ethnopharmacology,
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
May 1978, Lancet (London, England),
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
January 1980, Thrombosis research,
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
December 2012, Revista de biologia tropical,
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
April 2021, Environmental science and pollution research international,
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
January 2017, BioMed research international,
Mohammed El Haouari, and Mohamed Bnouham, and Mourad Bendahou, and Mohammed Aziz, and Abderrahim Ziyyat, and Abdelkhaleq Legssyer, and Hassane Mekhfi
September 2007, Alternative medicine review : a journal of clinical therapeutic,
Copied contents to your clipboard!